Participants were randomly assigned 2:1 to weekly semaglutide subcutaneous 1.0 mg (n=71) or placebo (n=35) for 52 weeks
How the FDA's change affects Medicare spending will depend in part on how many Part D plans add coverage for Wegovy, and the extent to which plans will restrict coverage, researchers said
It is important to remember that taste alterations can result from numerous other causes, including dental disease, oral infections, vitamin deficiencies, other medications, and systemic conditions such as diabetes itself
Smoothie King may have been one of the first large national chains to introduce a menu specifically labeled for GLP-1 users, but its far from the only restaurant responding to changing eating patterns
Why we landed on 0.10% and printed it Three principles drove the number: Stay in the evidence-supported, well-tolerated range for a copper signaling peptide, rather than chasing a high number for marketing
It promotes the energy metabolism of fats